Gonadorelin is a trophic peptide hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. GnRH is synthesized and released from GnRH neurons within the hypothalamus. The peptide belongs to gonadotropin-releasing hormone family. It constitutes the initial step in the hypothalamic–pituitary–gonadal axis.
CAT No: 10-101-166
CAS No: 33515-09-2(net)
Synonyms/Alias: GONADORELIN;Luliberin;Gonadorelina;Gonadorelinum;33515-09-2;Fertagyl;LH-Releasing factor;Luteostimulin;Relefact;Lutal;GnRH-I;Gonadotropin-releasing factor;Mammalian GnRH;Synthetic LRF;Dirigestran Spofa;Synthetic Gn-RH;Mammalian LH-RH;Synthetic LH-RF;Synthetic LH-RH;Porchine LH-RH;Hypocrine;Human LH-RH;Ovine LH-RH;LH-RH (swine);Synthetic gonadoliberin;Gonadoreline;Synthetic LH-FSH-RH;Gonadoliberin I;5-oxo-PHWSYGLRPGNH2;Synthetic LH-RH/FSH-RH;LH-Releasing factor (pig);Porcine LH-releasing factor;Synthetic LH-releasing factor;CHEBI:5520;Human gonadoliberin-i;p-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2;UNII-9O7312W37G;Gonadorelin decapeptide;Synthetic decapeptide FSH/LH-RH;HOE 471;EINECS 251-553-1;Gonadorelinum [INN-Latin];Gonadorelina [INN-Spanish];AY 24031;9034-40-6;LH-RH;Dirigestran;Glycinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolyl-;Gonadorelinum (INN-Latin);Gonadorelina (INN-Spanish);5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycinamide;AY-24031;Gn-RH;Luforan;Lutrefact;Nialutin;Relisorm l;LFRH;LHFSHRH;pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2;LH-RF;Gonadorelin [INN:BAN];71447-49-9;Fertelin, OvaCyst;Fertagyl (TN);EINECS 232-895-0;Gonadorelin (INN);AY 24034;CHEMBL1007;GONADORELIN (MART.);SCHEMBL143114;[125I]-GnRH I;GTPL3786;DTXSID20873490;H01CA01;V04CM01;5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (human or pig);BDBM50422274;AKOS015895122;AKOS030213247;9O7312W37G;CCG-270650;HS-2014;[125I]GnRH I (human, mouse, rat);Luteinizing hormone-areleasing factor (swine);D08027;pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-GlyNH2;GONADORELIN (GONADORELIN DECAPEPTIDE (GNRH));pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH(2);BRD-K96874295-015-01-0;GONADOTROPIN-RELEASING HORMONE (GNRH) ANALOGUE;Q20817116;5-OXOPRO-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-GLY-NH2;LUTEINISING HORMONE-RELEASING FACTOR (LNRH) ANALOGUE;251-553-1;5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl- glycyl-L-leucyl-L-arginyl-L-prolyl-glycinamide;L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycinamide;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C55H75N17O13 |
M.W/Mr. | 1182.3 |
Sequence | One Letter Code:XHWSYGLRPG Three Letter Code:H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 |
Application | Gonadorelin is also known as LHRH. After a transient increase, continuous administration results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. |
Appearance | Solid powder |
Activity | Agonist |
Biological Activity | Gonadorelin is a synthetic decapeptide with a structure identical with the natural Gonadotrophin. Releasing Hormone (Gn-RH) in mammalian species. |
Target | Gonadotropin-releasing hormone receptor |
Length | 10 |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
InChI | InChI=1S/C55H75N17O13/c1-29(2)19-38(49(80)67-37(9-5-17-60-55(57)58)54(85)72-18-6-10-43(72)53(84)62-25-44(56)75)66-46(77)26-63-47(78)39(20-30-11-13-33(74)14-12-30)68-52(83)42(27-73)71-50(81)40(21-31-23-61-35-8-4-3-7-34(31)35)69-51(82)41(22-32-24-59-28-64-32)70-48(79)36-15-16-45(76)65-36/h3-4,7-8,11-14,23-24,28-29,36-43,61,73-74H,5-6,9-10,15-22,25-27H2,1-2H3,(H2,56,75)(H,59,64)(H,62,84)(H,63,78)(H,65,76)(H,66,77)(H,67,80)(H,68,83)(H,69,82)(H,70,79)(H,71,81)(H4,57,58,60)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 |
InChI Key | XLXSAKCOAKORKW-AQJXLSMYSA-N |
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com